Short stature due to primary acid-labile subunit deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Short stature due to primary acid-labile subunit deficiency.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Short stature due to primary acid-labile subunit deficiency.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Increlex

(Mecasermin)Orphan drugstandard

Eton Pharmaceuticals, Inc.

12.1 Mechanism of Action Insulin-like growth factor-1 (IGF-1) is a key hormonal mediator on statural growth. Under normal circumstances, growth hormon...

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Short stature due to primary acid-labile subunit deficiency.
Search all trials →

Search clinical trials for Short stature due to primary acid-labile subunit deficiency →

Recent News & Research

No recent news articles indexed yet for Short stature due to primary acid-labile subunit deficiency.
Search PubMed for Short stature due to primary acid-labile subunit deficiency →

Browse all Short stature due to primary acid-labile subunit deficiency news →

Specialist Network

No specialists currently listed for Short stature due to primary acid-labile subunit deficiency.

View all Short stature due to primary acid-labile subunit deficiency specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles